A Putative Adverse Outcome Pathway Network for Disrupted Female Pubertal Onset to Improve Testing and Regulation of Endocrine Disrupting Chemicals

Delphine Franssen, Terje Svingen, David Lopez Rodriguez, Majorie Van Duursen, Julie Boberg, Anne-Simone Parent*

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

66 Downloads (Pure)

Abstract

The average age for pubertal onset in girls has declined over recent decades. Epidemiological studies in humans and experimental studies in animals suggest a causal role for endocrine disrupting chemicals (EDCs) that are present in our environment. Of concern, current testing and screening regimens are inadequate in identifying EDCs that may affect pubertal maturation, not least because they do not consider early-life exposure. Also, the causal relationship between EDC exposure and pubertal timing is still a matter of debate. To address this issue, we have used current knowledge to elaborate a network of putative adverse outcome pathways (pAOPs) to identify how chemicals can affect pubertal onset. By using the AOP framework, we highlight current gaps in mechanistic understanding that need to be addressed and simultaneously point towards events causative of pubertal disturbance that could be exploited for alternative test methods. We propose 6 pAOPs that could explain the disruption of pubertal timing by interfering with the central hypothalamic trigger of puberty, GnRH neurons, and by so doing highlight specific modes of action that could be targeted for alternative test method development.

Original languageEnglish
Pages (from-to)101-114
Number of pages14
JournalNeuroendocrinology
Volume112
Issue number2
Early online date26 Feb 2021
DOIs
Publication statusPublished - Feb 2022

Bibliographical note

© 2021 S. Karger AG, Basel.

Keywords

  • Puberty
  • reproduction
  • Endocrine disrupting chemicals

Fingerprint

Dive into the research topics of 'A Putative Adverse Outcome Pathway Network for Disrupted Female Pubertal Onset to Improve Testing and Regulation of Endocrine Disrupting Chemicals'. Together they form a unique fingerprint.

Cite this